Exact Sciences Corporation (FRA:EXK)

Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of EUR 16.76 billion. The enterprise value is 18.09 billion.

Market Cap	16.76B
Enterprise Value	18.09B

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	190.89M
Shares Outstanding	n/a
Shares Change (YoY)	+2.44%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	189.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	81.22
PS Ratio	6.06
PB Ratio	8.19
P/TBV Ratio	n/a
P/FCF Ratio	55.15
P/OCF Ratio	40.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 187.80, with an EV/FCF ratio of 59.54.

EV / Earnings	-102.15
EV / Sales	6.56
EV / EBITDA	187.80
EV / EBIT	n/a
EV / FCF	59.54

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 1.06.

Current Ratio	2.43
Quick Ratio	1.97
Debt / Equity	1.06
Debt / EBITDA	22.34
Debt / FCF	7.10
Interest Coverage	-3.81

Financial Efficiency

Return on equity (ROE) is -8.66% and return on invested capital (ROIC) is -1.86%.

Return on Equity (ROE)	-8.66%
Return on Assets (ROA)	-1.59%
Return on Invested Capital (ROIC)	-1.86%
Return on Capital Employed (ROCE)	-2.88%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	386,778
Profits Per Employee	-24,771
Employee Count	7,150
Asset Turnover	0.55
Inventory Turnover	5.99

Taxes

In the past 12 months, Exact Sciences has paid 3.46 million in taxes.

Income Tax	3.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+85.23%
50-Day Moving Average	86.53
200-Day Moving Average	59.26
Relative Strength Index (RSI)	59.57
Average Volume (20 Days)	0

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.83

Income Statement

In the last 12 months, Exact Sciences had revenue of EUR 2.77 billion and -177.11 million in losses. Loss per share was -0.94.

Revenue	2.77B
Gross Profit	1.93B
Operating Income	-127.86M
Pretax Income	-173.65M
Net Income	-177.11M
EBITDA	60.86M
EBIT	-127.86M
Loss Per Share	-0.94

Balance Sheet

The company has 821.64 million in cash and 2.16 billion in debt, with a net cash position of -1.34 billion.

Cash & Cash Equivalents	821.64M
Total Debt	2.16B
Net Cash	-1.34B
Net Cash Per Share	n/a
Equity (Book Value)	2.04B
Book Value Per Share	10.72
Working Capital	779.05M

Cash Flow

In the last 12 months, operating cash flow was 418.56 million and capital expenditures -114.69 million, giving a free cash flow of 303.87 million.

Operating Cash Flow	418.56M
Capital Expenditures	-114.69M
Free Cash Flow	303.87M
FCF Per Share	n/a

Margins

Gross margin is 69.69%, with operating and profit margins of -4.62% and -6.40%.

Gross Margin	69.69%
Operating Margin	-4.62%
Pretax Margin	-6.28%
Profit Margin	-6.40%
EBITDA Margin	2.20%
EBIT Margin	-4.62%
FCF Margin	10.99%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.44%
Shareholder Yield	-2.44%
Earnings Yield	-1.06%
FCF Yield	1.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.43
Piotroski F-Score	5